Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 2.13 M1.96 M1.99 M2.59 M 8.67 M Research & development 955 K568 K462 K420 K 2.4 M Operating income -3.09 M-2.53 M-2.45 M-3.01 M -11.08 M Non-Operating Income, Total -272 K1.59 M134 K131 K 1.58 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses -272 K1.59 M134 K131 K 1.58 M Unusual income/expense ———— — Pretax income -3.36 M-938 K-2.31 M-2.88 M -9.49 M Equity in earnings ———— — Taxes 000-1.7 M -1.7 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -3.36 M-938 K-2.31 M-1.18 M -7.79 M Discontinued operations ———— — Net income -3.36 M-938 K-2.31 M-1.18 M -7.79 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -3.36 M-938 K-2.31 M-1.18 M -7.79 M Basic earnings per share (Basic EPS) -0.21-0.06-0.14-0.06 -0.47 Diluted earnings per share (Diluted EPS) -0.21-0.06-0.14-0.06 -0.47 Average basic shares outstanding 15.92 M15.92 M16.93 M16.51 M — Diluted shares outstanding 15.92 M15.92 M16.93 M16.51 M — EBITDA -2.12 M-1.97 M-1.98 M-2.59 M -8.67 M EBIT -2.13 M-1.97 M-1.98 M-2.6 M -8.67 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 2 00003 0002 000 7 000